Placebo (Intranasal)

BIOLOGICAL2 trials

Sponsors

Janssen Research & Development, LLC, Osivax

Conditions

Depressive Disorder, MajorInfluenza

Phase 1

A Study to Evaluate the Effects of a Single-Dose and Repeat-Administration of Intranasal Esketamine on On-Road Driving in Participants With Major Depressive Disorder

CompletedNCT02919579

Janssen Research & Development, LLCDepressive Disorder, Major

Start: 2016-10-07End: 2018-06-29Updated: 2025-04-27

Safety and Immune Response of Increasing Doses of OVX836 After Intramuscular or Intranasal Administrations in Healthy Subjects

CompletedNCT03594890

OsivaxInfluenza

Start: 2018-06-12End: 2019-08-07Updated: 2022-09-22